APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Oral Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Oral Analgesics Market Outlook and Growth Opportunities 2026

22 December 2025214 pages

Choose your research edition.

Industry ResearchOTC Oral Analgesics Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Oral Analgesics Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal OTC Oral Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Oral Analgesics Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Oral Analgesics Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global OTC Oral Analgesics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Oral Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Oral Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Oral Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Oral Analgesics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Oral Analgesics market include Rundu Pharmaceutical, Yuanhe Pharmaceutical, Xinxiang Xinhui Yaoye, Southwest Pharmaceutical, Topfond Pharmaceutical, Sun Pharmaceutical, Sandoz, Sanofi and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global OTC Oral Analgesics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Oral Analgesics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Oral Analgesics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Oral Analgesics market.

OTC Oral Analgesics Segment by Company

Rundu Pharmaceutical

Yuanhe Pharmaceutical

Xinxiang Xinhui Yaoye

Southwest Pharmaceutical

Topfond Pharmaceutical

Sun Pharmaceutical

Sandoz

Sanofi

Johnson & Johnson

Novartis

Jiangxi Pharmaceutical

Hongxing Pharmaceutical

Pfizer

Huazhong Pharmaceutical

Dingchang Pharmaceutical

Guangdong Heping Pharmacy

Bangmin Pharmaceutical

GSK

Bayer

AstraZeneca

Taisho Pharmaceutical

SSP Co. Ltd.

MSD

Merck Group

Mallinckrodt

Kowa Company

Janssen Pharmaceuticals

Hisamitsu Pharmaceutical

Endo Pharmaceuticals

OTC Oral Analgesics Segment by Type

Aspirin

Ibuprofen

Acetaminophen

Naproxen

Other

OTC Oral Analgesics Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

OTC Oral Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global OTC Oral Analgesics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the OTC Oral Analgesics key companies, revenue, market share, and recent developments.

3. To split the OTC Oral Analgesics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions OTC Oral Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Oral Analgesics significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Oral Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Oral Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Oral Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Oral Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Oral Analgesics industry.

Chapter 3: Detailed analysis of OTC Oral Analgesics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of OTC Oral Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of OTC Oral Analgesics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Oral Analgesics Industry Trends Table 2. OTC Oral Analgesics Industry Drivers Table 3. OTC Oral Analgesics Industry Opportunities and Challenges Table 4. OTC Oral Analgesics Industry Restraints Table 5. Global OTC Oral Analgesics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Oral Analgesics Revenue Share by Company (2021-2026) Table 7. Global OTC Oral Analgesics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global OTC Oral Analgesics Key Company Manufacturing Base & Headquarters Table 9. Global OTC Oral Analgesics Company, Product Type & Application Table 10. Global OTC Oral Analgesics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global OTC Oral Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Aspirin Table 15. Significant Companies of Ibuprofen Table 16. Significant Companies of Acetaminophen Table 17. Significant Companies of Naproxen Table 18. Significant Companies of Other Table 19. Global OTC Oral Analgesics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global OTC Oral Analgesics Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global OTC Oral Analgesics Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global OTC Oral Analgesics Sales Value Share by Type (2021-2026) Table 23. Global OTC Oral Analgesics Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Pharmacies Table 25. Significant Companies of Online Pharmacies Table 26. Significant Companies of Retail Pharmacies Table 27. Global OTC Oral Analgesics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global OTC Oral Analgesics Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global OTC Oral Analgesics Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global OTC Oral Analgesics Sales Value Share by Application (2021-2026) Table 31. Global OTC Oral Analgesics Sales Value Share by Application (2027-2032) Table 32. Global OTC Oral Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global OTC Oral Analgesics Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global OTC Oral Analgesics Sales Value Share by Region (2021-2026) Table 35. Global OTC Oral Analgesics Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global OTC Oral Analgesics Sales Value Share by Region (2027-2032) Table 37. Global OTC Oral Analgesics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global OTC Oral Analgesics Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global OTC Oral Analgesics Sales Value Market Share by Country (2021-2026) Table 40. Global OTC Oral Analgesics Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global OTC Oral Analgesics Sales Value Market Share by Country (2027-2032) Table 42. Rundu Pharmaceutical Company Information Table 43. Rundu Pharmaceutical Business Overview Table 44. Rundu Pharmaceutical OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Rundu Pharmaceutical OTC Oral Analgesics Product Portfolio Table 46. Rundu Pharmaceutical Recent Development Table 47. Yuanhe Pharmaceutical Company Information Table 48. Yuanhe Pharmaceutical Business Overview Table 49. Yuanhe Pharmaceutical OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Yuanhe Pharmaceutical OTC Oral Analgesics Product Portfolio Table 51. Yuanhe Pharmaceutical Recent Development Table 52. Xinxiang Xinhui Yaoye Company Information Table 53. Xinxiang Xinhui Yaoye Business Overview Table 54. Xinxiang Xinhui Yaoye OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Xinxiang Xinhui Yaoye OTC Oral Analgesics Product Portfolio Table 56. Xinxiang Xinhui Yaoye Recent Development Table 57. Southwest Pharmaceutical Company Information Table 58. Southwest Pharmaceutical Business Overview Table 59. Southwest Pharmaceutical OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Southwest Pharmaceutical OTC Oral Analgesics Product Portfolio Table 61. Southwest Pharmaceutical Recent Development Table 62. Topfond Pharmaceutical Company Information Table 63. Topfond Pharmaceutical Business Overview Table 64. Topfond Pharmaceutical OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Topfond Pharmaceutical OTC Oral Analgesics Product Portfolio Table 66. Topfond Pharmaceutical Recent Development Table 67. Sun Pharmaceutical Company Information Table 68. Sun Pharmaceutical Business Overview Table 69. Sun Pharmaceutical OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sun Pharmaceutical OTC Oral Analgesics Product Portfolio Table 71. Sun Pharmaceutical Recent Development Table 72. Sandoz Company Information Table 73. Sandoz Business Overview Table 74. Sandoz OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sandoz OTC Oral Analgesics Product Portfolio Table 76. Sandoz Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sanofi OTC Oral Analgesics Product Portfolio Table 81. Sanofi Recent Development Table 82. Johnson & Johnson Company Information Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Johnson & Johnson OTC Oral Analgesics Product Portfolio Table 86. Johnson & Johnson Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis OTC Oral Analgesics Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Novartis OTC Oral Analgesics Product Portfolio Table 91. Novartis Recent Development Table 92. Jiangxi Pharmaceutical Company Information Table 93. Jiangxi Pharmaceutical Business Overview Table 94. Jiangxi Pharmaceutical OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Jiangxi Pharmaceutical OTC Oral Analgesics Product Portfolio Table 96. Jiangxi Pharmaceutical Recent Development Table 97. Hongxing Pharmaceutical Company Information Table 98. Hongxing Pharmaceutical Business Overview Table 99. Hongxing Pharmaceutical OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Hongxing Pharmaceutical OTC Oral Analgesics Product Portfolio Table 101. Hongxing Pharmaceutical Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Pfizer OTC Oral Analgesics Product Portfolio Table 106. Pfizer Recent Development Table 107. Huazhong Pharmaceutical Company Information Table 108. Huazhong Pharmaceutical Business Overview Table 109. Huazhong Pharmaceutical OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Huazhong Pharmaceutical OTC Oral Analgesics Product Portfolio Table 111. Huazhong Pharmaceutical Recent Development Table 112. Dingchang Pharmaceutical Company Information Table 113. Dingchang Pharmaceutical Business Overview Table 114. Dingchang Pharmaceutical OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Dingchang Pharmaceutical OTC Oral Analgesics Product Portfolio Table 116. Dingchang Pharmaceutical Recent Development Table 117. Guangdong Heping Pharmacy Company Information Table 118. Guangdong Heping Pharmacy Business Overview Table 119. Guangdong Heping Pharmacy OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Guangdong Heping Pharmacy OTC Oral Analgesics Product Portfolio Table 121. Guangdong Heping Pharmacy Recent Development Table 122. Bangmin Pharmaceutical Company Information Table 123. Bangmin Pharmaceutical Business Overview Table 124. Bangmin Pharmaceutical OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Bangmin Pharmaceutical OTC Oral Analgesics Product Portfolio Table 126. Bangmin Pharmaceutical Recent Development Table 127. GSK Company Information Table 128. GSK Business Overview Table 129. GSK OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. GSK OTC Oral Analgesics Product Portfolio Table 131. GSK Recent Development Table 132. Bayer Company Information Table 133. Bayer Business Overview Table 134. Bayer OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Bayer OTC Oral Analgesics Product Portfolio Table 136. Bayer Recent Development Table 137. AstraZeneca Company Information Table 138. AstraZeneca Business Overview Table 139. AstraZeneca OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. AstraZeneca OTC Oral Analgesics Product Portfolio Table 141. AstraZeneca Recent Development Table 142. Taisho Pharmaceutical Company Information Table 143. Taisho Pharmaceutical Business Overview Table 144. Taisho Pharmaceutical OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Taisho Pharmaceutical OTC Oral Analgesics Product Portfolio Table 146. Taisho Pharmaceutical Recent Development Table 147. SSP Co. Ltd. Company Information Table 148. SSP Co. Ltd. Business Overview Table 149. SSP Co. Ltd. OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. SSP Co. Ltd. OTC Oral Analgesics Product Portfolio Table 151. SSP Co. Ltd. Recent Development Table 152. MSD Company Information Table 153. MSD Business Overview Table 154. MSD OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. MSD OTC Oral Analgesics Product Portfolio Table 156. MSD Recent Development Table 157. Merck Group Company Information Table 158. Merck Group Business Overview Table 159. Merck Group OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 160. Merck Group OTC Oral Analgesics Product Portfolio Table 161. Merck Group Recent Development Table 162. Mallinckrodt Company Information Table 163. Mallinckrodt Business Overview Table 164. Mallinckrodt OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 165. Mallinckrodt OTC Oral Analgesics Product Portfolio Table 166. Mallinckrodt Recent Development Table 167. Kowa Company Company Information Table 168. Kowa Company Business Overview Table 169. Kowa Company OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 170. Kowa Company OTC Oral Analgesics Product Portfolio Table 171. Kowa Company Recent Development Table 172. Janssen Pharmaceuticals Company Information Table 173. Janssen Pharmaceuticals Business Overview Table 174. Janssen Pharmaceuticals OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 175. Janssen Pharmaceuticals OTC Oral Analgesics Product Portfolio Table 176. Janssen Pharmaceuticals Recent Development Table 177. Hisamitsu Pharmaceutical Company Information Table 178. Hisamitsu Pharmaceutical Business Overview Table 179. Hisamitsu Pharmaceutical OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 180. Hisamitsu Pharmaceutical OTC Oral Analgesics Product Portfolio Table 181. Hisamitsu Pharmaceutical Recent Development Table 182. Endo Pharmaceuticals Company Information Table 183. Endo Pharmaceuticals Business Overview Table 184. Endo Pharmaceuticals OTC Oral Analgesics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 185. Endo Pharmaceuticals OTC Oral Analgesics Product Portfolio Table 186. Endo Pharmaceuticals Recent Development Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. OTC Oral Analgesics Product Image Figure 2. Global OTC Oral Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Oral Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global OTC Oral Analgesics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Aspirin Image Figure 8. Ibuprofen Image Figure 9. Acetaminophen Image Figure 10. Naproxen Image Figure 11. Other Image Figure 12. Global OTC Oral Analgesics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global OTC Oral Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global OTC Oral Analgesics Sales Value Share by Type (2021-2032) Figure 15. Hospital Pharmacies Image Figure 16. Online Pharmacies Image Figure 17. Retail Pharmacies Image Figure 18. Global OTC Oral Analgesics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global OTC Oral Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global OTC Oral Analgesics Sales Value Share by Application (2021-2032) Figure 21. Global OTC Oral Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global OTC Oral Analgesics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America OTC Oral Analgesics Sales Value (2021-2032) & (US$ Million) Figure 24. North America OTC Oral Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe OTC Oral Analgesics Sales Value (2021-2032) & (US$ Million) Figure 26. Europe OTC Oral Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific OTC Oral Analgesics Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific OTC Oral Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America OTC Oral Analgesics Sales Value (2021-2032) & (US$ Million) Figure 30. South America OTC Oral Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa OTC Oral Analgesics Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa OTC Oral Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt OTC Oral Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Aspirin
  • Ibuprofen
  • Acetaminophen
  • Naproxen
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Rundu Pharmaceutical
  • Yuanhe Pharmaceutical
  • Xinxiang Xinhui Yaoye
  • Southwest Pharmaceutical
  • Topfond Pharmaceutical
  • Sun Pharmaceutical
  • Sandoz
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Jiangxi Pharmaceutical
  • Hongxing Pharmaceutical
  • Pfizer
  • Huazhong Pharmaceutical
  • Dingchang Pharmaceutical
  • Guangdong Heping Pharmacy
  • Bangmin Pharmaceutical
  • GSK
  • Bayer
  • AstraZeneca
  • Taisho Pharmaceutical
  • SSP Co. Ltd.
  • MSD
  • Merck Group
  • Mallinckrodt
  • Kowa Company
  • Janssen Pharmaceuticals
  • Hisamitsu Pharmaceutical
  • Endo Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global OTC Oral Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global OTC Oral Analgesics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 OTC Oral Analgesics Market Dynamics
  1. 2.1 OTC Oral Analgesics Industry Trends
  2. 2.2 OTC Oral Analgesics Industry Drivers
  3. 2.3 OTC Oral Analgesics Industry Opportunities and Challenges
  4. 2.4 OTC Oral Analgesics Industry Restraints
3 OTC Oral Analgesics Market by Company
  1. 3.1 Global OTC Oral Analgesics Company Revenue Ranking in 2025
  2. 3.2 Global OTC Oral Analgesics Revenue by Company (2021-2026)
  3. 3.3 Global OTC Oral Analgesics Company Ranking (2024-2026)
  4. 3.4 Global OTC Oral Analgesics Company Manufacturing Base and Headquarters
  5. 3.5 Global OTC Oral Analgesics Company Product Type and Application
  6. 3.6 Global OTC Oral Analgesics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global OTC Oral Analgesics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 OTC Oral Analgesics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 OTC Oral Analgesics Market by Type
  1. 4.1 OTC Oral Analgesics Type Introduction
  2. 4.1.1 Aspirin
  3. 4.1.2 Ibuprofen
  4. 4.1.3 Acetaminophen
  5. 4.1.4 Naproxen
  6. 4.1.5 Other
  7. 4.2 Global OTC Oral Analgesics Sales Value by Type
  8. 4.2.1 Global OTC Oral Analgesics Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global OTC Oral Analgesics Sales Value by Type (2021-2032)
  10. 4.2.3 Global OTC Oral Analgesics Sales Value Share by Type (2021-2032)
5 OTC Oral Analgesics Market by Application
  1. 5.1 OTC Oral Analgesics Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global OTC Oral Analgesics Sales Value by Application
  6. 5.2.1 Global OTC Oral Analgesics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Oral Analgesics Sales Value by Application (2021-2032)
  8. 5.2.3 Global OTC Oral Analgesics Sales Value Share by Application (2021-2032)
6 OTC Oral Analgesics Regional Value Analysis
  1. 6.1 Global OTC Oral Analgesics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Oral Analgesics Sales Value by Region (2021-2032)
  3. 6.2.1 Global OTC Oral Analgesics Sales Value by Region: 2021-2026
  4. 6.2.2 Global OTC Oral Analgesics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America OTC Oral Analgesics Sales Value (2021-2032)
  7. 6.3.2 North America OTC Oral Analgesics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe OTC Oral Analgesics Sales Value (2021-2032)
  10. 6.4.2 Europe OTC Oral Analgesics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific OTC Oral Analgesics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific OTC Oral Analgesics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America OTC Oral Analgesics Sales Value (2021-2032)
  16. 6.6.2 South America OTC Oral Analgesics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa OTC Oral Analgesics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa OTC Oral Analgesics Sales Value Share by Country, 2025 VS 2032
7 OTC Oral Analgesics Country-level Value Analysis
  1. 7.1 Global OTC Oral Analgesics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Oral Analgesics Sales Value by Country (2021-2032)
  3. 7.2.1 Global OTC Oral Analgesics Sales Value by Country (2021-2026)
  4. 7.2.2 Global OTC Oral Analgesics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt OTC Oral Analgesics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt OTC Oral Analgesics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt OTC Oral Analgesics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Rundu Pharmaceutical
  2. 8.1.1 Rundu Pharmaceutical Company Information
  3. 8.1.2 Rundu Pharmaceutical Business Overview
  4. 8.1.3 Rundu Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Rundu Pharmaceutical OTC Oral Analgesics Product Portfolio
  6. 8.1.5 Rundu Pharmaceutical Recent Developments
  7. 8.2 Yuanhe Pharmaceutical
  8. 8.2.1 Yuanhe Pharmaceutical Company Information
  9. 8.2.2 Yuanhe Pharmaceutical Business Overview
  10. 8.2.3 Yuanhe Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yuanhe Pharmaceutical OTC Oral Analgesics Product Portfolio
  12. 8.2.5 Yuanhe Pharmaceutical Recent Developments
  13. 8.3 Xinxiang Xinhui Yaoye
  14. 8.3.1 Xinxiang Xinhui Yaoye Company Information
  15. 8.3.2 Xinxiang Xinhui Yaoye Business Overview
  16. 8.3.3 Xinxiang Xinhui Yaoye OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xinxiang Xinhui Yaoye OTC Oral Analgesics Product Portfolio
  18. 8.3.5 Xinxiang Xinhui Yaoye Recent Developments
  19. 8.4 Southwest Pharmaceutical
  20. 8.4.1 Southwest Pharmaceutical Company Information
  21. 8.4.2 Southwest Pharmaceutical Business Overview
  22. 8.4.3 Southwest Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Southwest Pharmaceutical OTC Oral Analgesics Product Portfolio
  24. 8.4.5 Southwest Pharmaceutical Recent Developments
  25. 8.5 Topfond Pharmaceutical
  26. 8.5.1 Topfond Pharmaceutical Company Information
  27. 8.5.2 Topfond Pharmaceutical Business Overview
  28. 8.5.3 Topfond Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Topfond Pharmaceutical OTC Oral Analgesics Product Portfolio
  30. 8.5.5 Topfond Pharmaceutical Recent Developments
  31. 8.6 Sun Pharmaceutical
  32. 8.6.1 Sun Pharmaceutical Company Information
  33. 8.6.2 Sun Pharmaceutical Business Overview
  34. 8.6.3 Sun Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharmaceutical OTC Oral Analgesics Product Portfolio
  36. 8.6.5 Sun Pharmaceutical Recent Developments
  37. 8.7 Sandoz
  38. 8.7.1 Sandoz Company Information
  39. 8.7.2 Sandoz Business Overview
  40. 8.7.3 Sandoz OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz OTC Oral Analgesics Product Portfolio
  42. 8.7.5 Sandoz Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi OTC Oral Analgesics Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson OTC Oral Analgesics Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis OTC Oral Analgesics Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Jiangxi Pharmaceutical
  62. 8.11.1 Jiangxi Pharmaceutical Company Information
  63. 8.11.2 Jiangxi Pharmaceutical Business Overview
  64. 8.11.3 Jiangxi Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangxi Pharmaceutical OTC Oral Analgesics Product Portfolio
  66. 8.11.5 Jiangxi Pharmaceutical Recent Developments
  67. 8.12 Hongxing Pharmaceutical
  68. 8.12.1 Hongxing Pharmaceutical Company Information
  69. 8.12.2 Hongxing Pharmaceutical Business Overview
  70. 8.12.3 Hongxing Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hongxing Pharmaceutical OTC Oral Analgesics Product Portfolio
  72. 8.12.5 Hongxing Pharmaceutical Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer OTC Oral Analgesics Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Huazhong Pharmaceutical
  80. 8.14.1 Huazhong Pharmaceutical Company Information
  81. 8.14.2 Huazhong Pharmaceutical Business Overview
  82. 8.14.3 Huazhong Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Huazhong Pharmaceutical OTC Oral Analgesics Product Portfolio
  84. 8.14.5 Huazhong Pharmaceutical Recent Developments
  85. 8.15 Dingchang Pharmaceutical
  86. 8.15.1 Dingchang Pharmaceutical Company Information
  87. 8.15.2 Dingchang Pharmaceutical Business Overview
  88. 8.15.3 Dingchang Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dingchang Pharmaceutical OTC Oral Analgesics Product Portfolio
  90. 8.15.5 Dingchang Pharmaceutical Recent Developments
  91. 8.16 Guangdong Heping Pharmacy
  92. 8.16.1 Guangdong Heping Pharmacy Company Information
  93. 8.16.2 Guangdong Heping Pharmacy Business Overview
  94. 8.16.3 Guangdong Heping Pharmacy OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangdong Heping Pharmacy OTC Oral Analgesics Product Portfolio
  96. 8.16.5 Guangdong Heping Pharmacy Recent Developments
  97. 8.17 Bangmin Pharmaceutical
  98. 8.17.1 Bangmin Pharmaceutical Company Information
  99. 8.17.2 Bangmin Pharmaceutical Business Overview
  100. 8.17.3 Bangmin Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bangmin Pharmaceutical OTC Oral Analgesics Product Portfolio
  102. 8.17.5 Bangmin Pharmaceutical Recent Developments
  103. 8.18 GSK
  104. 8.18.1 GSK Company Information
  105. 8.18.2 GSK Business Overview
  106. 8.18.3 GSK OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  107. 8.18.4 GSK OTC Oral Analgesics Product Portfolio
  108. 8.18.5 GSK Recent Developments
  109. 8.19 Bayer
  110. 8.19.1 Bayer Company Information
  111. 8.19.2 Bayer Business Overview
  112. 8.19.3 Bayer OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bayer OTC Oral Analgesics Product Portfolio
  114. 8.19.5 Bayer Recent Developments
  115. 8.20 AstraZeneca
  116. 8.20.1 AstraZeneca Company Information
  117. 8.20.2 AstraZeneca Business Overview
  118. 8.20.3 AstraZeneca OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  119. 8.20.4 AstraZeneca OTC Oral Analgesics Product Portfolio
  120. 8.20.5 AstraZeneca Recent Developments
  121. 8.21 Taisho Pharmaceutical
  122. 8.21.1 Taisho Pharmaceutical Company Information
  123. 8.21.2 Taisho Pharmaceutical Business Overview
  124. 8.21.3 Taisho Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Taisho Pharmaceutical OTC Oral Analgesics Product Portfolio
  126. 8.21.5 Taisho Pharmaceutical Recent Developments
  127. 8.22 SSP Co. Ltd.
  128. 8.22.1 SSP Co. Ltd. Company Information
  129. 8.22.2 SSP Co. Ltd. Business Overview
  130. 8.22.3 SSP Co. Ltd. OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  131. 8.22.4 SSP Co. Ltd. OTC Oral Analgesics Product Portfolio
  132. 8.22.5 SSP Co. Ltd. Recent Developments
  133. 8.23 MSD
  134. 8.23.1 MSD Company Information
  135. 8.23.2 MSD Business Overview
  136. 8.23.3 MSD OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  137. 8.23.4 MSD OTC Oral Analgesics Product Portfolio
  138. 8.23.5 MSD Recent Developments
  139. 8.24 Merck Group
  140. 8.24.1 Merck Group Company Information
  141. 8.24.2 Merck Group Business Overview
  142. 8.24.3 Merck Group OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Merck Group OTC Oral Analgesics Product Portfolio
  144. 8.24.5 Merck Group Recent Developments
  145. 8.25 Mallinckrodt
  146. 8.25.1 Mallinckrodt Company Information
  147. 8.25.2 Mallinckrodt Business Overview
  148. 8.25.3 Mallinckrodt OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Mallinckrodt OTC Oral Analgesics Product Portfolio
  150. 8.25.5 Mallinckrodt Recent Developments
  151. 8.26 Kowa Company
  152. 8.26.1 Kowa Company Company Information
  153. 8.26.2 Kowa Company Business Overview
  154. 8.26.3 Kowa Company OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Kowa Company OTC Oral Analgesics Product Portfolio
  156. 8.26.5 Kowa Company Recent Developments
  157. 8.27 Janssen Pharmaceuticals
  158. 8.27.1 Janssen Pharmaceuticals Company Information
  159. 8.27.2 Janssen Pharmaceuticals Business Overview
  160. 8.27.3 Janssen Pharmaceuticals OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Janssen Pharmaceuticals OTC Oral Analgesics Product Portfolio
  162. 8.27.5 Janssen Pharmaceuticals Recent Developments
  163. 8.28 Hisamitsu Pharmaceutical
  164. 8.28.1 Hisamitsu Pharmaceutical Company Information
  165. 8.28.2 Hisamitsu Pharmaceutical Business Overview
  166. 8.28.3 Hisamitsu Pharmaceutical OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Hisamitsu Pharmaceutical OTC Oral Analgesics Product Portfolio
  168. 8.28.5 Hisamitsu Pharmaceutical Recent Developments
  169. 8.29 Endo Pharmaceuticals
  170. 8.29.1 Endo Pharmaceuticals Company Information
  171. 8.29.2 Endo Pharmaceuticals Business Overview
  172. 8.29.3 Endo Pharmaceuticals OTC Oral Analgesics Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Endo Pharmaceuticals OTC Oral Analgesics Product Portfolio
  174. 8.29.5 Endo Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst